Cargando…

In vitro fertilisation with recombinant follicle stimulating hormone requires less IU usage compared with highly purified human menopausal gonadotrophin: results from a European retrospective observational chart review

BACKGROUND: Previous studies have reported conflicting results for the comparative doses of recombinant follicle stimulating hormone (rFSH) and highly purified human menopausal gonadotrophin (hMG-HP) required per cycle of in vitro fertilisation (IVF); the aim of this study was to determine the avera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trew, Geoffrey H, Brown, Adam P, Gillard, Samantha, Blackmore, Stuart, Clewlow, Christine, O'Donohoe, Paul, Wasiak, Radoslaw
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993713/ https://www.ncbi.nlm.nih.gov/pubmed/21059191 http://dx.doi.org/10.1186/1477-7827-8-137

Ejemplares similares

Recombinant human follicle-stimulating hormone produces more oocytes with a lower total dose per cycle in assisted reproductive technologies compared with highly purified human menopausal gonadotrophin: a meta-analysis
por: Lehert, Philippe, et al.
Publicado: (2010)

The Menopausal Transition: Is the Hair Follicle “Going through Menopause”?
por: Rinaldi, Fabio, et al.
Publicado: (2023)

Effects of 17β-oestradiol and norethisterone acetate on sulfonation and sialylation of gonadotrophins in post-menopausal women
por: Wide, Leif, et al.
Publicado: (2010)

Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin in Normogonadotropic Infertile Patients
por: Hua, Rui, et al.
Publicado: (2013)

300 IU vs. 200 IU of OnabotulinumtoxinA for detrusor overactivity
por: Persu, Cristian
Publicado: (2014)

Gonadotrophins: The future
por: Patil, Madhuri
Publicado: (2014)

Endocrine profile following stimulation with recombinant follicle stimulating hormone and luteinizing hormone versus highly purified human menopausal gonadotropin
por: Requena, Antonio, et al.
Publicado: (2014)

Consecutive versus concomitant follicle-stimulating hormone and highly purified human menopausal gonadotropin: A milder response but better quality
por: Maghraby, Hassan Ali, et al.
Publicado: (2022)

Human Gonadotrophin Secretion
por: Franchimont, P.
Publicado: (1972)

Low-dose human menopausal gonadotrophin versus natural cycles in intrauterine insemination for subfertile couples with regular menstruation
por: Li, Sichen, et al.
Publicado: (2020)

Cardiac Murmurs Iu Chorea
Publicado: (1871)

Vitamin D(3) Supplementation: Comparison of 1000 IU and 2000 IU Dose in Healthy Individuals
por: Dědečková, Eva, et al.
Publicado: (2023)

No effect of monthly supplementation with 12000 IU, 24000 IU or 48000 IU vitamin D3 for one year on muscle function: The vitamin D in older people study
por: Ranathunga, R.M.T.K., et al.
Publicado: (2019)

The effect of human chorionic gonadotrophin contained in human menopausal gonadotropin on the clinical outcomes during progestin-primed ovarian stimulation
por: Zhu, Xiuxian, et al.
Publicado: (2017)

IU professor contributes to particle accelerator
Publicado: (2008)

Increasing the human chorionic gonadotrophin cut-off to ≤1000 IU/l for starting actinomycin D in post-molar gestational trophoblastic neoplasia developing resistance to methotrexate spares more women multi-agent chemotherapy
por: Cortés-Charry, R., et al.
Publicado: (2021)

Predictors of In Vitro Fertilization Outcomes in Women with Highest Follicle-Stimulating Hormone Levels ≥12 IU/L: A Prospective Cohort Study
por: Huang, Lina N., et al.
Publicado: (2015)

A Randomized Control Trial of 3 IU IV Oxytocin Bolus with 7 IU Oxytocin Infusion versus 10 IU Oxytocin Infusion During Cesarean Section for Prevention of Postpartum Hemorrhage
por: Yaliwal, Rajasri G, et al.
Publicado: (2020)

Anaesthesia for In Vitro Fertilisation
por: Jain, Divya, et al.
Publicado: (2009)

Endometriosis and in vitro fertilisation
por: Vassilopoulou, Loukia, et al.
Publicado: (2018)

Views of Foundation Doctors (Year 2) on Distress Likely with Genital Examination in Children
por: O'Donohoe, Jarlath M
Publicado: (2011)

Gonadotrophin abnormalities in an infant with Lowe syndrome
por: Warner, Bronwen E, et al.
Publicado: (2017)

Anti-Xa activities following 5,000 IU and 7,500 IU of s.c. dalteparin in critically ill patients and 5,000 IU in medical patients: a prospective randomized study
por: Heinz, GH, et al.
Publicado: (2013)

IU physicists help unlock universe's secrets
Publicado: (2003)

What is the feasibility of switching to 200IU OnabotulinumtoxinA in patients with detrusor overactivity who have previously received 300IU?
por: Malki, Manar, et al.
Publicado: (2014)

Expression of membrane fusion proteins in spermatozoa and total fertilisation failure during in vitro fertilisation
por: Enoiu, Simona Ioana, et al.
Publicado: (2022)

Economic evaluation of highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone in fresh and frozen in vitro fertilization/intracytoplasmic sperm-injection cycles in Sweden
por: Wex, Jaro, et al.
Publicado: (2013)

OVARIAN STEROID CELLS : I. Differentiation of the Lutein Cell from the Granulosa Follicle Cell during the Preovulatory Stage and under the Influence of Exogenous Gonadotrophins
por: Blanchette, E. Joan
Publicado: (1966)

Recent Advancements in In Vitro Fertilisation
por: Singh, Kadambari, et al.
Publicado: (2022)

Vitamin D supplementation in older people (VDOP): Study protocol for a randomised controlled intervention trial with monthly oral dosing with 12,000 IU, 24,000 IU or 48,000 IU of vitamin D(3)
por: Schoenmakers, Inez, et al.
Publicado: (2013)

ELECTROPHORETIC HOMOGENEITY OF PREGNANT MARE SERUM GONADOTROPHIN
por: Li, Choh Hao, et al.
Publicado: (1940)

Chorionic Gonadotrophin, ACTH, and the Adrenal-Hyaluronidase Relationship
por: Opsahl, Jeanette C., et al.
Publicado: (1951)

Enhancement of human chorionic gonadotrophin production by antimetabolites.
por: Browne, P., et al.
Publicado: (1982)

Gonadotrophin releasing hormone antagonist in IVF/ICSI
por: MS, Kamath, et al.
Publicado: (2008)

Gonadotrophin stimulation and risk of relapse in breast cancer
por: Fredriksson, A, et al.
Publicado: (2021)

The average gonadotrophin dosage per follicle is predictive of ovarian response and cumulative live birth chances after in vitro fertilization: a retrospective cohort study
por: Liu, Shan, et al.
Publicado: (2023)

Genetic markers of ovarian follicle number and menopause in women of multiple ethnicities
por: Schuh-Huerta, Sonya M., et al.
Publicado: (2012)

Live birth after letrozole as an adjunct to follicle-stimulating hormone versus follicle-stimulating hormone alone for ovarian stimulation in in vitro fertilisation cycles—study protocol for a randomised controlled trial
por: Guo, Wei, et al.
Publicado: (2022)

The effect of gonadotrophin-releasing hormone agonist versus human chorionic gonadotrophin trigger on pregnancy and neonatal outcomes in Letrozole-HMG IUI cycles
por: Chen, Li, et al.
Publicado: (2023)

Response of the Sparrow Testis to Various Kinds and Amounts of Gonadotrophins
por: Pfeiffer, Carroll A.
Publicado: (1952)

Cannot write session to /tmp/vufind_sessions/sess_dgmud8g7ii9b83tu4h7looe0n7